Moderna

The Latest

  • Study Finds Vaccinated Lactating Moms’ Breast Milk Tainted With COVID Vaccines
    VACCINE DEATH
    Mothers and would-be moms who haven't been vaccinated against COVID would be glad to know they didn't get jabbed after a new study found something very interesting-even concerning.
  • Moderna mRNA Patent Ignites Lawsuit Against Pfizer-BioNTech
    mRNA vax
    Pfizer and BioNTech are being sued by Moderna for patents on life-saving technology that they claim to have filed years ago.
  • U.S. Panel Set To Authorize COVID Vaccine For Young Children
    Moderna
    Pfizer and Moderna vaccines use messenger RNA technology to deliver genetic code for the coronavirus spike protein to human cells.
  • Moderna COVID Vaccine Safe for Children Under Five: FDA
    VACCINE, BABY
    If vaccines are approved during a meeting next week, children under the age of five may be able to obtain doses shortly.
  • Moderna Seeks Authorization for COVID-19 Vaccine for Very Young Children by End of April
    Moderna
    Moderna is hoping to get authorization to provide a pediatric COVID-19 vaccine with a low dose to children aged 6 months to under 6 years old.
  • Moderna Begins Trial On Omicron-Specific Booster Shot
    Moderna
    Moderna said it will be conducting mid-stage studies on its new Omicron-specific booster in the U.S.
  • COVID-19 Vaccine For 5 Years And Under: When, What To Expect
    VACCINE, BABY
    Vaccinating kids against COVID is the best way to prevent long-term health ramifications.
  • Moderna Says Omicron Variant Vaccine Coming In Early 2022
    FIGHTING OMICRON
    Moderna said it has already deployed hundreds of its employees to study the new variant.
  • FDA Approves Johnson & Johnson, Moderna COVID-19 Boosters, Clears ‘Mix And Match’ Shots
    EFFECTIVE
    The guidelines allow anyone who received the J&J vaccine to get a shot of the Moderna or Pfizer vaccine as booster.
  • Moderna Not Sharing Its Vaccine Formula, Opts To Expand Production Instead
    Moderna
    Moderna's co-founder and chairman, Noubar Afeyan, said it would be better for the company to increase its production of vaccines as opposed to sharing its technology.
1   2   3